Albemarle Reports Record Quarterly Net Sales and Operati...(90 Total current liabilities ...),Health

Total current liabilities 408,638 402,917

Long-term debt 861,065 707,311

Other noncurrent liabilities 330,654 334,828

Deferred income taxes 125,718 107,089

Shareholders' equity 1,249,320 1,278,305

Total liabilities & shareholders' equity $2,975,395 $2,830,450

See accompanying notes to the condensed consolidated financial information.

Albemarle Corporation and Subsidiaries

Selected Cash Flows Data

(In Thousands of Dollars) (Unaudited)

Three Months Ended

March 31,

2008 2007

Cash and cash equivalents at beginning of year $130,551 $149,499

Cash and cash equivalents at end of period $135,130 $125,016

Sources of cash and cash equivalents:

Net income 63,261 58,108

Proceeds from borrowings 199,928 17,824

Proceeds from exercise of stock options 3,398 10,952

Uses of cash and cash equivalents:

Capital expenditures (20,139) (26,241)

Purchases of common stock (151,137) (18,647)

Repayments of long-term debt (45,273) (12,441)

Dividends paid to shareholders (9,707) (8,628)

Dividends paid to minority interests (5,486) (4,374)

Non-cash items:

Depreciation and amortization 26,542 27,349

See accompanying notes to the condensed consolidated financial information.
'/>"/>